Close Menu

NEW YORK – Eurobio Scientific said on Tuesday that it has received CE marking for its EBX 042 FluCoSyn test, which can identify viruses for the main flu-like symptoms.

The Paris-based firm said the RT-PCR assay can be used to test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus from one patient sample. More specifically, the multiplex kit has five targets, the R and N genes for SARS-CoV-2; one common target for influenza A and B; one target for RSV; and one target for the control integrated into each test to validate the correct functioning of the reaction.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.